SEC Form 4 · accession 0001127602-18-032479
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Johst
Officer — Corporate Executive VP
Period of report
Nov 7, 2018
Accepted (ET)
Nov 8, 2018 · 1:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 7, 2018 | M | 23,356 | $59.41 | A | 219,849 | D | |
| Common Stock | Nov 7, 2018 | S | 23,356 | $136.00 | D | 196,493 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $59.41 | Nov 7, 2018 | M | 23,356 | D | Feb 28, 2015 | Feb 28, 2021 | Common Stock | 23,356 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.